Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials
出版年份 2019 全文链接
标题
Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials
作者
关键词
-
出版物
NEUROPSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-26
DOI
10.1038/s41386-019-0573-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: A systematic review and meta-analysis
- (2019) Kentaro Matsui et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic treatment in the maintenance phase of schizophrenia: An updated systematic review of the guidelines and algorithms
- (2019) Yutaro Shimomura et al. SCHIZOPHRENIA RESEARCH
- Dose reduction of high-dose first-generation antipsychotics or switch to ziprasidone in long-stay patients with schizophrenia: A 1-year double-blind randomized clinical trial
- (2018) Jan P.A.M. Bogers et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Dose reduction of risperidone and olanzapine can improve cognitive function and negative symptoms in stable schizophrenic patients: A single-blinded, 52-week, randomized controlled study
- (2018) Yanling Zhou et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effect of discontinuation v. maintenance of antipsychotic medication on relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis
- (2018) Taro Kishi et al. PSYCHOLOGICAL MEDICINE
- Correspondence between negative symptoms and potential sources of secondary negative symptoms over time
- (2017) Aida Farreny et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis
- (2017) Albert Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review
- (2017) Meghan Bowtell et al. SCHIZOPHRENIA RESEARCH
- Age-related changes in binding of the D 2/3 receptor radioligand [ 11 C](+)PHNO in healthy volunteers
- (2016) David Matuskey et al. NEUROIMAGE
- Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials
- (2015) Y Iwata et al. MOLECULAR PSYCHIATRY
- Extrapyramidal symptoms and cognitive test performance in patients with schizophrenia
- (2015) Gagan Fervaha et al. SCHIZOPHRENIA RESEARCH
- Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia
- (2015) Ariel Graff-Guerrero et al. JAMA Psychiatry
- Evaluation of the Individual Safe Correction of Antipsychotic Agent Polypharmacy in Japanese Patients with Chronic Schizophrenia: Validation of Safe Corrections for Antipsychotic Polypharmacy and the High-Dose Method
- (2015) Y. Yamanouchi et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method
- (2014) S. Leucht et al. SCHIZOPHRENIA BULLETIN
- Therapeutic Window for Striatal Dopamine D2/3 Receptor Occupancy in Older Patients with Schizophrenia: A Pilot PET Study
- (2013) Hiroyuki Uchida et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis
- (2013) G. Désaméricq et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study
- (2013) H. Takeuchi et al. SCHIZOPHRENIA BULLETIN
- Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
- (2012) Stefan Leucht et al. LANCET
- Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data
- (2012) Hitoshi Sakurai et al. SCHIZOPHRENIA BULLETIN
- Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control
- (2011) Roshan Cools et al. BIOLOGICAL PSYCHIATRY
- Several prescription patterns of antipsychotic drugs influence cognitive functions in Japanese chronic schizophrenia patients
- (2011) Hikaru Hori et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Dopamine D2 Receptor Occupancy and Clinical Effects
- (2011) Hiroyuki Uchida et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Risperidone Maintenance Treatment in Schizophrenia: A Randomized, Controlled Trial
- (2010) Chuan-Yue Wang et al. AMERICAN JOURNAL OF PSYCHIATRY
- Processing Speed Deficits in Schizophrenia: Reexamining the Evidence
- (2010) Emma E.M. Knowles et al. AMERICAN JOURNAL OF PSYCHIATRY
- International Consensus Study of Antipsychotic Dosing
- (2010) David M. Gardner et al. AMERICAN JOURNAL OF PSYCHIATRY
- Increased Antipsychotic Sensitivity in Elderly Patients
- (2009) Hiroyuki Uchida et al. JOURNAL OF CLINICAL PSYCHIATRY
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
- (2009) Wayne A. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations.
- (2009) Maria de Gracia Dominguez et al. PSYCHOLOGICAL BULLETIN
- Low Dose vs Standard Dose of Antipsychotics for Relapse Prevention in Schizophrenia: Meta-analysis
- (2009) Hiroyuki Uchida et al. SCHIZOPHRENIA BULLETIN
- The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity
- (2008) Keith H. Nuechterlein et al. AMERICAN JOURNAL OF PSYCHIATRY
- Strategies of treatment with olanzapine in schizophrenic patients during stable phase: Results of a pilot study
- (2008) Frédéric Rouillon et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started